Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy

There is an unmet need for better diagnostic tools to further delineate clinical subsets of heterogeneous chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and multifocal motor neuropathy (MMN) to facilitate treatment decisions. Corneal confocal microscopy (CCM) is a noninvasive and reproducible nerve imaging technique. This study evaluates the potential of CCM as a diagnostic surrogate in CIDP and MMN.

[1]  J. Pedespan,et al.  Childhood CIDP: Study of 31 patients and comparison between slow and rapid-onset groups , 2015, Brain and Development.

[2]  R. Hughes,et al.  Chronic in fl ammatory demyelinating polyradiculoneuropathy: from pathology to phenotype , 2022 .

[3]  Minshan Jiang,et al.  Corneal confocal microscopy for assessment of diabetic peripheral neuropathy: a meta-analysis , 2015, British Journal of Ophthalmology.

[4]  G. Fink,et al.  Corneal confocal microscopy detects small fiber damage in chronic inflammatory demyelinating polyneuropathy (CIDP) , 2014, Journal of the peripheral nervous system : JPNS.

[5]  L. E. Lovblom,et al.  Response to Comment on Breiner et al. Does the Prevailing Hypothesis That Small-Fiber Dysfunction Precedes Large-Fiber Dysfunction Apply to Type 1 Diabetic Patients? Diabetes Care 2014;37:1418–1424 , 2014, Diabetes Care.

[6]  M. Dimachkie,et al.  Acquired Immune Demyelinating Neuropathies , 2014, Continuum.

[7]  T. Kanda,et al.  Severity and Patterns of Blood-Nerve Barrier Breakdown in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Correlations with Clinical Subtypes , 2014, PloS one.

[8]  N. Latov.  Diagnosis and treatment of chronic acquired demyelinating polyneuropathies , 2014, Nature Reviews Neurology.

[9]  T. Brannagan,et al.  Comparison of sensitivity and specificity among 15 criteria for chronic inflammatory demyelinating polyneuropathy , 2014, Muscle & nerve.

[10]  S. P. Patel,et al.  Corneal Sensitivity in Chronic Inflammatory Demyelinating Polyneuropathy , 2014, Cornea.

[11]  Nuha M. Alkhawajah,et al.  Comparison of monoclonal gammopathy of undetermined significance-associated neuropathy and chronic inflammatory demyelinating polyneuropathy patients , 2014, Journal of Neurology.

[12]  B. Vollmar,et al.  Diabetes mellitus leads to accumulation of dendritic cells and nerve fiber damage of the subbasal nerve plexus in the cornea. , 2014, Investigative ophthalmology & visual science.

[13]  L. H. van den Berg,et al.  MMN: From Immunological Cross-Talk to Conduction Block , 2014, Journal of Clinical Immunology.

[14]  Xin Chen,et al.  Rapid automated diagnosis of diabetic peripheral neuropathy with in vivo corneal confocal microscopy. , 2014, Investigative ophthalmology & visual science.

[15]  L. E. Lovblom,et al.  Does the Prevailing Hypothesis That Small-Fiber Dysfunction Precedes Large-Fiber Dysfunction Apply to Type 1 Diabetic Patients? , 2014, Diabetes Care.

[16]  S. McMahon,et al.  Chemokines as peripheral pain mediators , 2013, Neuroscience Letters.

[17]  N. Yuki,et al.  Axonal Guillain-Barré syndrome: concepts and controversies , 2013, The Lancet Neurology.

[18]  A. Boulton,et al.  Corneal Nerve Loss Detected With Corneal Confocal Microscopy Is Symmetrical and Related to the Severity of Diabetic Polyneuropathy , 2013, Diabetes Care.

[19]  D. Bender,et al.  Neurogenic factor-induced Langerhans cell activation in diabetic mice with mechanical allodynia , 2013, Journal of Neuroinflammation.

[20]  K. Digre,et al.  Corneal confocal microscopy is efficient, well‐tolerated, and reproducible , 2013, Journal of the peripheral nervous system : JPNS.

[21]  Nathan Efron,et al.  Corneal Confocal Microscopy Detects Early Nerve Regeneration in Diabetic Neuropathy After Simultaneous Pancreas and Kidney Transplantation , 2012, Diabetes.

[22]  S. Kusunoki,et al.  Clinical features of CIDP with LM1-associated antibodies , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[23]  A. Kampik,et al.  Distribution of Antigen Presenting Cells in the Human Cornea: Correlation of In Vivo Confocal Microscopy and Immunohistochemistry in Different Pathologic Entities , 2012, Current eye research.

[24]  Mitra Tavakoli,et al.  Corneal confocal microscopy detects small‐fiber neuropathy in Charcot–Marie–Tooth disease type 1A patients , 2012, Muscle & nerve.

[25]  M. Sabatelli,et al.  Clinical and pathological heterogeneity in a series of 31 patients with IgM-related neuropathy , 2012, Journal of the Neurological Sciences.

[26]  Catharina G. Faber,et al.  Small-fibre neuropathies—advances in diagnosis, pathophysiology and management , 2012, Nature Reviews Neurology.

[27]  J. Valls-Solé,et al.  Epidermal Langerhans cells in small fiber neuropathies , 2012, PAIN®.

[28]  A. Orszag,et al.  Reproducibility of in vivo corneal confocal microscopy as a novel screening test for early diabetic sensorimotor polyneuropathy , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[29]  M. A. Dabbah,et al.  Automatic analysis of diabetic peripheral neuropathy using multi-scale quantitative morphology of nerve fibres in corneal confocal microscopy imaging , 2011, Medical Image Anal..

[30]  C. Sommer,et al.  A modified score to identify and discriminate neuropathic pain: a study on the German version of the neuropathic pain symptom inventory (NPSI) , 2011, BMC neurology.

[31]  A. Boulton,et al.  Increased Langerhan cell density and corneal nerve damage in diabetic patients: role of immune mechanisms in human diabetic neuropathy. , 2011, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[32]  P. Bergh,et al.  European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision , 2010, Journal of the peripheral nervous system : JPNS.

[33]  J. Graham,et al.  Repeatability of Measuring Corneal Subbasal Nerve Fiber Length in Individuals With Type 2 Diabetes , 2010, Eye & contact lens.

[34]  Belgium,et al.  European Federation of Neurological Societies/Peripheral Nerve Society Guideline * on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision , 2010, Journal of the peripheral nervous system : JPNS.

[35]  C. Sommer,et al.  Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition , 2010, The Lancet Neurology.

[36]  Nathan Efron,et al.  Corneal confocal microscopy: A novel noninvasive means to diagnose neuropathy in patients with fabry disease , 2009, Muscle & nerve.

[37]  Nathan Efron,et al.  Corneal confocal microscopy: A novel means to detect nerve fibre damage in idiopathic small fibre neuropathy , 2009, Experimental Neurology.

[38]  C. Benaïm,et al.  Do patients having a decrease in SNAP amplitude during the course of MMN present with a different condition? , 2009, Journal of Neurology.

[39]  P. Bouche,et al.  Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[40]  V. Lambrecq,et al.  Sensory loss in multifocal motor neuropathy: A clinical and electrophysiological study , 2009, Muscle & nerve.

[41]  H. Hartung,et al.  Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial , 2008, The Lancet Neurology.

[42]  M. Yanagisawa,et al.  In Vivo Confocal Microscopy of Hereditary Sensory and Autonomic Neuropathy , 2008, Current eye research.

[43]  N. Romani,et al.  Characterization of antigen-presenting cells in fresh and cultured human corneas using novel dendritic cell markers. , 2007, Investigative ophthalmology & visual science.

[44]  Nathan Efron,et al.  Surrogate Markers of Small Fiber Damage in Human Diabetic Neuropathy , 2007, Diabetes.

[45]  P. Palange,et al.  From the authors , 2007, European Respiratory Journal.

[46]  Kanxing Zhao,et al.  Existence of small slow-cycling Langerhans cells in the limbal basal epithelium that express ABCG2. , 2007, Experimental eye research.

[47]  R. Gold,et al.  Therapy of immune neuropathies with intravenous immunoglobulins , 2006, Journal of Neurology.

[48]  J. Pollard,et al.  European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society , 2006, European journal of neurology.

[49]  European Federation of Neurological Societies/Peripheral Nerve Society Guideline * on management of paraproteinemic demyelinating neuropathies. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society , 2006, Journal of the peripheral nervous system : JPNS.

[50]  B. Vollmar,et al.  In vivo confocal microscopic evaluation of Langerhans cell density and distribution in the normal human corneal epithelium , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[51]  P. Fuhr,et al.  IgM deposits on skin nerves in anti–myelin‐associated glycoprotein neuropathy , 2005, Annals of neurology.

[52]  T. Maisonobe,et al.  Polyneuropathy associated with IgG/IgA monoclonal gammopathy: a clinical and electrophysiological study of 15 cases , 2003, European journal of neurology.

[53]  J. Vallat,et al.  Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: Evaluation of eight cases , 2003, Muscle & nerve.

[54]  P. Schmitz,et al.  Connecting impairment, disability, and handicap in immune mediated polyneuropathies , 2003, Journal of neurology, neurosurgery, and psychiatry.

[55]  M. Chiang,et al.  Cutaneous innervation in chronic inflammatory demyelinating polyneuropathy , 2002, Neurology.

[56]  R. Weinstein,et al.  Efficacy of intravenous immunoglobulin in patients with IgG monoclonal gammopathy and polyneuropathy. , 2002, Archives of neurology.

[57]  G. Comi,et al.  Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy , 2001, Annals of neurology.

[58]  Hans-Peter Hartung,et al.  The role of macrophages in immune-mediated damage to the peripheral nervous system , 2001, Progress in Neurobiology.

[59]  N. Yuki,et al.  Axonal Guillain‐Barré syndrome: Relation to anti‐ganglioside antibodies and Campylobacter jejuni infection in Japan , 2000, Annals of neurology.

[60]  H. Mizusawa,et al.  Glycosphingolipid antibodies and blood–nerve barrier in autoimmune demyelinative neuropathy , 2000, Neurology.

[61]  J. Kaplan,et al.  Late motor involvement in cases presenting as “chronic sensory demyelinating polyneuropathy” , 1995, Muscle & nerve.

[62]  S. Boniface,et al.  Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[63]  J. Heckman,et al.  Electrodiagnosis in diseases of nerve and muscle. , 1984, Orthopedics.

[64]  Mark J. Brown,et al.  Multifocal demyelinating neuropathy with persistent conduction block , 1982, Neurology.

[65]  H. Franssen,et al.  Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies , 2012, Nature Reviews Neurology.

[66]  P. Bergh,et al.  EFNS/PNS CIDP GUIDELINES European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - F , 2010 .

[67]  M. Kentenich,et al.  Unmyelinated fibers in sural nerve biopsies of chronic inflammatory demyelinating polyneuropathy , 2004, Acta Neuropathologica.